MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.annemergmed.2024.10.013

Медицинская библиотека · Annals of emergency medicine · 2024

Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study.

Koehl Jenny, Spolsdoff Devin, Negaard Briana, Lewis Alison, Santiago Ruben, Krenz James, Polotti Alyssa, Feldman Ryan, Slocum Giles, Zimmerman David, Howington Gavin T, Sarangarm Preeyaporn, Mattson Alicia E, Brown Caitlin, Zepeski Anne, Rech Megan A, Faine Brett

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

STUDY

OBJECTIVE

The primary objective of our study was to compare the effectiveness of oral cephalosporins versus fluroquinolones and trimethoprim/sulfamethoxazole (TMP-SMX) for the treatment of pyelonephritis in patients discharged home from the emergency department (ED).

METHODS

This was a multicenter, retrospective, observational cohort study of 11 geographically diverse US EDs. Patients aged ≥18 years diagnosed with pyelonephritis and discharged home from the ED between January 1, 2021 and October 31, 2023 were included. The primary outcome was treatment failure at 14 days defined as a composite outcome of the following: (1) recurrence of urinary symptoms, (2) repeat ED visit or hospitalization for a urinary tract infection, (3) receipt of a new antibiotic prescription for urinary tract infection. Secondary outcome was appropriateness of empiric treatment based on urine culture susceptibility.

RESULTS

Among the 851 patients who met inclusion criteria, 647 patients received a cephalosporin, and 204 patients received an Infectious Diseases Society of America guideline-endorsed first-line treatment (fluroquinolones, TMP-SMX). Overall, baseline characteristics were similar between the 2 cohorts. Rates of treatment failure were not significantly different in the cephalosporin group compared with the fluroquinolone/TMP-SMX groups (17.2% of cephalosporin vs 22.5% of fluroquinolone/TMP-SMX group, difference=5.3%, 95% confidence interval -0.118 to 0.01). After adjusting for potential confounders, cephalosporin use was not associated with treatment failure (odds ratio=0.22, 95% confidence interval 0.03 to 1.95). There was no difference in rates of appropriate empiric treatment based on urine culture susceptibility.

CONCLUSION

Oral cephalosporins were associated with similar treatment failure rates compared with Infectious Diseases Society of America guideline-endorsed treatments for the treatment of pyelonephritis in ED patients discharged home.

Для цитирования: Koehl Jenny, Spolsdoff Devin, Negaard Briana, Lewis Alison, Santiago Ruben, Krenz James, Polotti Alyssa, Feldman Ryan, Slocum Giles, Zimmerman David, Howington Gavin T, Sarangarm Preeyaporn, Mattson Alicia E, Brown Caitlin, Zepeski Anne, Rech Megan A, Faine Brett. Cephalosporins for Outpatient Pyelonephritis in the Emergency Department: COPY-ED Study.. Annals of emergency medicine. 2024. DOI: 10.1016/j.annemergmed.2024.10.013.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.